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Introduction
Accurate description of the risk and nature of flares will
help counsel families when JIA is controlled and when
considering discontinuing treatment.
Objectives
To describe the probability and characteristics of flares
across JIA categories in an inception cohort of Canadian
children treated with a contemporary approach.
Methods
We studied children diagnosed with JIA between 2005 and
2010 who had at least one visit with inactive disease while
being prospectively followed in the Research in Arthritis
in Canadian Children emphasizing Outcomes (ReACCh-
Out) cohort. They received usual pediatric rheumatology
care at 16 Canadian centres. Flare was defined as any
recurrence of disease manifestations after attaining
inactive disease (no active joints, no extraarticular manifes-
tations and a physician global assessment <10mm). Flares
were considered major if they required re-initiation or
intensification (a new drug was started) of anti-rheumatic
treatment. Risk of flare was calculated with Kaplan-Meier
survival methods starting at the time of attainment of
inactive disease, and at the time of discontinuing all
treatment.
Results
Of 1492 children recruited in ReACCh-Out, 1128 had at
least one visit with inactive disease. Median follow-up was
24 months (IQR 12, 39) after attaining inactive disease.
A total of 1,179 flares were observed in 532 patients; 55%
of all flares were major flares. The cumulative probability
of flare was 25%, 42% and 60% within 6, 12 and 24 months
after attaining inactive disease, respectively. By 24 months
the risk varied from 49% for systemic JIA to 72% for
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Table 1 Cumulative probability of flare within 6 and 12 months of stopping treatment
JIA category Subjects stopping treatment / total Risk within 6 months (%) Risk within 12 months (%)
Any flare Major flare Any flare Major flare
Systemic arthritis 37 / 66 11 3 11 3
Psoriatic arthritis 44 / 75 12 12 15 15
Oligoarthritis 318 / 481 15 12 32 26
Undifferentiated arthritis 60/ 111 24 13 28 18
Enthesitis-related arthritis 77 / 152 29 21 45 33
RF-negative polyarthritis 85 / 209 25 20 45 40
RF-positive polyarthritis 4 / 34 - - - -
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RF-positive polyarthritis. 625 patients discontinued all
treatment. The probability of flares after stopping
treatment is shown in the Table (except for RF-positive
polyarthritis because only 4 subjects discontinued treat-
ment). Table 1
Conclusion
Flares after attaining inactive disease were common in this
JIA cohort, and the risk was lowest for systemic JIA and
highest for RF-positive polyarthritis. Flares after stopping
treatment were uncommon in systemic JIA, but occurred
in up to 45% of children within one year in other JIA
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